This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).
From 1 January 2022, the listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.
This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).
Updates to this page
Published 16 December 2021 Last updated 17 July 2024 +show all updates
Changed date in the date added column from 12 July 2027 to 12 July 2024 for 2 products: Spexotras 50micrograms/ml oral solution - Trametinib 50micrograms/ml oral solution sugar free and Voxelotor 500mg tablets.
Added to the list:Mounjaro KwikPen 15mg/0.6ml solution for injection 2.4ml pre-filled pens: Tirzepatide 15mg/0.6ml solution for injection 2.4ml pre-filled disposable devices,n/a: Voxelotor 500mg tablets,Finlee 10mg dispersible tablets: Dabrafenib 10mg dispersible tablets sugar free,Spexotras 50micrograms/ml oral solution: Trametinib 50micrograms/ml oral solution sugar free,Fluenz vaccine nasal suspension 0.2ml unit dose: Influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose.Removed from the list:Fluenz Tetra vaccine nasal suspension 0.2ml unit dose: Influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose.
Removed from the list: Mylotarg 5mg powder for concentrate for solution for infusion vials: Gemtuzumab ozogamicin 5mg powder for solution for infusion vials,Nevirapine 50mg/5ml oral suspension,Talazoparib 1mg capsules,Talazoparib 250microgram capsules.
Updated to add one product to the list: Takhyzro 150 mg solution for injection in pre-filled syringe - Lanadelumab 150 mg solution for injection in pre-filled syringe.
Removed from the list: HyQvia 10g/100ml solution for infusion and 5ml vials: Normal immunoglobulin human 10g/100ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 5ml vials,Not applicable: Streptokinase 1.5million unit powder for solution for infusion vials,Not applicable: Streptokinase 250,000unit powder for solution for infusion vials.
Updated to add and remove products. Added: Mounjaro KwikPen 7.5mg/0.6ml solution for injection 2.4ml pre-filled pens: Tirzepatide 7.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices; Mounjaro KwikPen 10mg/0.6ml solution for injection 2.4ml pre-filled pens: Tirzepatide 10mg/0.6ml solution for injection 2.4ml pre-filled disposable devices; Mounjaro KwikPen 12.5mg/0.6ml solution for injection 2.4ml pre-filled pens: Tirzepatide 12.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices.Removed: Briviact 10mg/ml oral solution: Brivaracetam 50mg/5ml oral solution sugar free; Oxaliplatin 200mg/40ml concentrate for solution for infusion vials.
Removed from the list - Dupixent 300mg/2ml solution for injection pre-filled syringes: Dupilumab 300mg/2ml solution for injection pre-filled syringes; Lucentis 1.65mg/0.165ml solution for injection pre-filled syringes: Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes; Nexpovio 20mg tablets: Selinexor 20mg tablets.
Updated to add and remove products. Added: Brivaracetam 75mg tablets. Removed Dalbavancin (Xydalba) 500mg powder for concentrate for solution for infusion vial.
Added to the list: Etrasimod 2mg tablets.
Added to the list: Bosutinib 400mg tablets and Azathioprine 10mg/ml oral suspension sugar free.
Added to the list: Nexpovio 20mg tablets: Selinexor 20mg tablets.
Updated to add and remove products. Added: Briviact 10mg/ml oral solution: Brivaracetam 50mg/5ml oral solution sugar free;Cholestagel 625mg tablets: Colesevelam 625mg tablets;Cresemba 200mg powder vials: Isavuconazole 200mg powder for solution for infusion vials. Removed:Lurasidone 37mg tablets.
Added 3 products to the list: Dupixent 300mg/2ml solution for injection pre-filled syringes: Dupilumab 300mg/2ml solution for injection pre-filled syringes; HyQvia 10g/100ml solution for infusion and 5ml vials: Normal immunoglobulin human 10g/100ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 5ml vials; and Trurapi 100 units/ml solution for injection in vial: insulin aspart 100 units/ml solution for injection in vial. Removed: Intuniv 4mg modified-release tablets: Guanfacine 4mg modified-release tablets.
